Participant Clinical Case Discussion: The Value of Everolimus as Second-line Treatment in Pancreatic NEN

Date 12 April 2019
Event ESMO Preceptorship on Gastroenteropancreatic Neuroendocrine Neoplasms Prague April 2019
Session Session 2, Multispecialist Therapeutic Approach
Topics Neuroendocrine Tumours
Anticancer Agents
Presenter M. Golcic, HR